Health Canada
- Status: approved
🇨🇦 Basiliximab 20 milligram [Simulect] in Canada
Basiliximab 20 milligram [Simulect] (Basiliximab 20 milligram [Simulect]) regulatory status in Canada.
Marketing authorisation
Basiliximab 20 milligram [Simulect] in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Basiliximab 20 milligram [Simulect] approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Basiliximab 20 milligram [Simulect] in Canada?
King Faisal Specialist Hospital & Research Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.